Literature DB >> 19133009

Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells.

Ulvi Kahraman Gursoy1, Eija Könönen, Veli-Jukka Uitto.   

Abstract

We examined survival and replication of fusobacteria inside epithelial cells. Subconfluent cultures of HaCaT keratinocytes were infected with five bacterial strains representing three Fusobacterium species: F. nucleatum, F. necrophorum, and F. mortiferum. Adhesion and invasion of the bacteria were assayed before and after antibiotic treatment that killed the adhered and extracellular bacteria. The number of live fusobacteria was examined by bacterial culturing after sonication of the epithelial cells. The role of host cell cytoskeleton functions was examined by treating the epithelial cells with cell function inhibitors. Number of viable epithelial cells was measured with the CellTiter96 kit. The tested Fusobacterium species adhered to and invaded the epithelial cells, and multiplied intracellularly for several hours. Thereafter, the intracellular number of bacteria rapidly declined. Concomitantly, viable fusobacteria were detected in the culture medium. Treatment of the infected epithelial cells with an actin formation inhibitor markedly reduced the number of living intracellular fusobacteria. Newly formed actin filaments were seen by confocal microscopy in the epithelial cells associated with the invaded bacteria. Fusobacteria infection did not reduce the number of viable epithelial cells in culture. Thus, fusobacteria are able to adhere to and invade epithelial cells, and survive under aerobic conditions. This property may enable them to survive in mucosa and participate in various disease processes of oral and pharyngeal tissues.

Entities:  

Mesh:

Year:  2008        PMID: 19133009     DOI: 10.1111/j.1600-0463.2008.00868.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

2.  Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration.

Authors:  Michael A Casasanta; Christopher C Yoo; Barath Udayasuryan; Blake E Sanders; Ariana Umaña; Yao Zhang; Huaiyao Peng; Alison J Duncan; Yueying Wang; Liwu Li; Scott S Verbridge; Daniel J Slade
Journal:  Sci Signal       Date:  2020-07-21       Impact factor: 8.192

3.  Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families.

Authors:  Ariana Umaña; Blake E Sanders; Christopher C Yoo; Michael A Casasanta; Barath Udayasuryan; Scott S Verbridge; Daniel J Slade
Journal:  J Bacteriol       Date:  2019-11-05       Impact factor: 3.490

4.  NLRX1 modulates differentially NLRP3 inflammasome activation and NF-κB signaling during Fusobacterium nucleatum infection.

Authors:  Shu-Chen Hung; Pei-Rong Huang; Cássio Luiz Coutinho Almeida-da-Silva; Kalina R Atanasova; Ozlem Yilmaz; David M Ojcius
Journal:  Microbes Infect       Date:  2017-10-09       Impact factor: 2.700

5.  Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.

Authors:  Yannick Eisele; Patrick M Mallea; Biljana Gigic; W Zac Stephens; Christy A Warby; Kate Buhrke; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Sheetal Hardikar; Lyen C Huang; T Bartley Pickron; Courtney L Scaife; Richard Viskochil; Torsten Koelsch; Anita R Peoples; Maria A Pletneva; Mary Bronner; Martin Schneider; Alexis B Ulrich; Eric A Swanson; Adetunji T Toriola; David Shibata; Christopher I Li; Erin M Siegel; Jane Figueiredo; Klaus-Peter Janssen; Hans Hauner; June Round; Cornelia M Ulrich; Andreana N Holowatyj; Jennifer Ose
Journal:  Clin Colorectal Cancer       Date:  2021-02-27       Impact factor: 4.035

6.  Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins.

Authors:  Andreas Zanzoni; Lionel Spinelli; Shérazade Braham; Christine Brun
Journal:  Microbiome       Date:  2017-08-10       Impact factor: 14.650

7.  Combined antioxidant effects of Neem extract, bacteria, red blood cells and Lysozyme: possible relation to periodontal disease.

Authors:  Leali Heyman; Yael Houri-Haddad; Samuel N Heyman; Isaac Ginsburg; Yossi Gleitman; Osnat Feuerstein
Journal:  BMC Complement Altern Med       Date:  2017-08-10       Impact factor: 3.659

8.  Fusobacterium Species and Subspecies Differentially Affect the Composition and Architecture of Supra- and Subgingival Biofilms Models.

Authors:  Thomas Thurnheer; Lamprini Karygianni; Manuela Flury; Georgios N Belibasakis
Journal:  Front Microbiol       Date:  2019-07-30       Impact factor: 5.640

9.  Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy.

Authors:  Hassan Alkharaan; Liyan Lu; Giorgio Gabarrini; Asif Halimi; Zeeshan Ateeb; Michał J Sobkowiak; Haleh Davanian; Carlos Fernández Moro; Leif Jansson; Marco Del Chiaro; Volkan Özenci; Margaret Sällberg Chen
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

10.  Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With M1 Macrophage Polarization in Hidradenitis Suppurativa.

Authors:  Paula Mariottoni; Simon W Jiang; Courtney A Prestwood; Vaibhav Jain; Jutamas Suwanpradid; Melodi Javid Whitley; Margaret Coates; David A Brown; Detlev Erdmann; David L Corcoran; Simon G Gregory; Tarannum Jaleel; Jennifer Y Zhang; Tamia A Harris-Tryon; Amanda S MacLeod
Journal:  Front Med (Lausanne)       Date:  2021-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.